Vaccination: Manufacturing Industries

(asked on 20th April 2020) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of the UK’s vaccine manufacturing capacity.


Answered by
Jo Churchill Portrait
Jo Churchill
Minister of State (Department for Work and Pensions)
This question was answered on 4th May 2020

The new Government ‘Vaccines Taskforce’ is working with the BioIndustry Association Taskforce to review existing domestic capability to manufacture vaccines, in response to COVID-19. The Taskforce is also reviewing options for increasing this capacity, including how to support the acceleration and expand the capacity of the Vaccines Manufacturing and Innovation Centre, so that it becomes operational earlier than planned and is able to manufacture population level doses.

For COVID-19, the type of vaccine manufacturing capacity needed will be determined by the nature of the vaccine that is developed and the technology used to produce the vaccines. This work is proceeding at pace, with the support of industry and academic partners, to ensure that we are identifying suitable capacity across different vaccine types, while those vaccines are still under development.

Reticulating Splines